CN104082741A - Soft seal oil capsule containing astaxanthin - Google Patents
Soft seal oil capsule containing astaxanthin Download PDFInfo
- Publication number
- CN104082741A CN104082741A CN201410297614.0A CN201410297614A CN104082741A CN 104082741 A CN104082741 A CN 104082741A CN 201410297614 A CN201410297614 A CN 201410297614A CN 104082741 A CN104082741 A CN 104082741A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- seal oil
- dha
- dpa
- epa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 22
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 22
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 22
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 22
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 22
- 239000002775 capsule Substances 0.000 title claims abstract description 8
- 239000003921 oil Substances 0.000 claims abstract description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 12
- 239000007901 soft capsule Substances 0.000 claims abstract description 9
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940031439 squalene Drugs 0.000 claims abstract description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims description 3
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021290 n-3 DPA Nutrition 0.000 claims description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 7
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract description 4
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 4
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 3
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 3
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 1
- 239000006014 omega-3 oil Substances 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides a soft seal oil capsule containing astaxanthin. The soft seal oil capsule comprises main effective components and main accessories, wherein the main effective components include seal oil [containing EPA (Eicosapentaenoic Acid), DHA (Docosahexaenoic Acid), DPA (Docosapentaenoic Acid), and squalene], and astaxanthin oil (containing the astaxanthin); the main accessories include water, vitamin E, glycerinum and edible animal gelatin. The seal oil soft capsule containing the astaxanthin has the benefits that highly-unsaturated omega-3 fatty acids (the EPA, the DHA and the DPA) are effectively combined with the astaxanthin having the strong antioxidant effect; the components are further synergetic; cardiovascular and cerebrovascular diseases can be effectively prevented; furthermore, the immunity can be enhanced; free radicals in a human body can be removed; the role of delaying senescence is played.
Description
(1) technical field
The present invention relates to a kind of soft capsule of fur seal, especially a kind of soft capsule of fur seal that contains astaxanthin, belongs to health food technology field.
(2) background technology
At present, along with improving constantly of living standard, people constantly increase the intake of higher fatty acid meat product, incident is the continuous rising of fat content in blood, and the diseases such as the arterial sclerosis causing thus, thrombus, coronary heart disease, affect and have endangered middle-aged and old Health and Living quality day by day.In order to prevent the generation of this type of disease, people start more edible seal oil series products, due to existing various seal oil series products ubiquities on market: active ingredient is simple, functional component content is low, functional component proportioning is unreasonable, cause that product function is single, the shortcoming of DeGrain, be difficult to play desirable prophylactic effect.
(3) summary of the invention
The present invention is in order to make up the deficiencies in the prior art, a kind of soft capsule of fur seal that contains astaxanthin is provided, main active ingredient is: seal oil [contain EPA(eicosapentaenoic acid), DHA(DHA), DPA(clupanodonic acid), squalene], astaxanthin, vitamin E, major auxiliary burden is water, glycerine and edible animal gelatin.
EPA in seal oil: be commonly called as " blood vessel street cleaner ", there is the vascular sclerosis of preventing, cardiovascular and cerebrovascular embolism, reduce hypertension, high fat of blood and cholesterol, suppress the effects such as platelet aggregation.Be applicable to coronary sclerosis and thrombus, headstroke, cerebral hemorrhage, cerebrovascular disorder, high cholesterol, high fat of blood, hypertension, hand and foot numbness, the various cardiovascular and cerebrovascular diseases such as palpitaition.DHA: being commonly called as " docosapentaenoic acid ", is the necessary nutriment of brain tissue and optic nerve development and Function.Can be used for strengthening memory, promote infant's intellectual development and improve IQ, prevention and treatment senile dementia.DPA: the immunity that can promote and improve human body.To diabetes, rheumatoid arthritis, psoriasis, asthma, ulcer colo-enteritis etc. all has therapeutic action.Squalene: natural.Contribute to anti-cancer and anticancer and skin care to make it smooth and full of elasticity.
Astaxanthin has in vivo remarkable rising HDL and falls effect of LDL, can be used to prevention of arterial sclerosis, coronary heart disease and ischemic brain damage.Astaxanthin has the activity of very strong inducing cell division, has important immunoregulation effect.Astaxanthin is easy to by blood-brain barrier and cell membrane; can effectively prevent the damage of amphiblestroid oxidation and photosensitive cell; and central nervous system is especially played a protective role to brain, especially more remarkable than lutein for the effect of senile macula retinae sex change.The strong anti-oxidation of astaxanthin may make it become potential bright protective agent, effectively removes the free radical that causes skin aging, stops skin photoage.
Vitamin E can protect highly unsaturated fatty acid (EPA, DHA, DPA) not oxidized, extends shelf life of products.The invention has the beneficial effects as follows, this soft capsule of fur seal effectively combines ω-3 highly unsaturated fatty acid (EPA, DHA, DPA) and astaxanthin, between composition, further acts synergistically, and can effectively prevent cardiovascular and cerebrovascular disease.And can improve immunity, remove interior free yl, play the effect delaying senility.
(4) detailed description of the invention
1, preparation content: by admixed together according to certain formula to raw material seal oil, astaxanthin oil, vitamin E, stir, the mass percent of capsule 's content functional component net content is EPA:10～15%, DHA:20～25%, DPA:10～15%, astaxanthin: 1～3%, squalene: 4～8%, and other the non-functional component in all the other vitamin E and seal oils that are 1%.
2, make capsule body material: taking edible gelatin, glycerine and pure water as utricule raw material, glycerine and pure water are proportionally injected in glue pot, and heating is stirred to 75 DEG C of left and right, then adds gelatin, continue to stir final vacuum deaeration in 20～30 minutes, make and obtain envelop materials.
3, the content preparing and capsule body are passed through to pelleting, moulding, wash ball, are dried, make finished product soft capsule of fur seal.
Claims (2)
1. a soft capsule of fur seal that contains astaxanthin, is characterized in that: the mass percent of capsule 's content raw material be seal oil [contain EPA(eicosapentaenoic acid), DHA(DHA), DPA(clupanodonic acid), squalene]: 80～94%, astaxanthin oil (containing astaxanthin): 5～19%, vitamin E: 1%.
2. a kind of soft capsule of fur seal that contains astaxanthin according to claim 1, it is characterized in that: the mass percent of capsule 's content functional component is: EPA:10～15%, DHA:20～25%, DPA:10～15%, astaxanthin: 1～3%, squalene 4～8%, other the non-functional component in all the other vitamin E and seal oils that are 1%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297614.0A CN104082741A (en) | 2014-06-29 | 2014-06-29 | Soft seal oil capsule containing astaxanthin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297614.0A CN104082741A (en) | 2014-06-29 | 2014-06-29 | Soft seal oil capsule containing astaxanthin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104082741A true CN104082741A (en) | 2014-10-08 |
Family
ID=51630589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410297614.0A Pending CN104082741A (en) | 2014-06-29 | 2014-06-29 | Soft seal oil capsule containing astaxanthin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104082741A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107080769A (en) * | 2017-05-17 | 2017-08-22 | 王茹 | A kind of natural drug for treating various chronic diseases and medical formula food |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518989A (en) * | 2003-01-21 | 2004-08-11 | 刘 威 | Soft capsule of fur seal and application in preparing health products for regulating blood fat |
| WO2005075613A1 (en) * | 2004-02-06 | 2005-08-18 | Adrien Beaudoin | Method for preventing the oxidation of lipids in animal and vegetable oils and compositions produced by the method thereof |
| CN101023963A (en) * | 2007-03-28 | 2007-08-29 | 汪昔奇 | Method for preparing natural astaxanthin and fishliver oil |
| US20090297492A1 (en) * | 2008-05-30 | 2009-12-03 | Yamaha Hatsudoki Kabushiki Kaisha | Method for Improving Cognitive Performance |
| CN103608022A (en) * | 2011-05-31 | 2014-02-26 | 日本水产株式会社 | Brain function improving agent |
| CN103800435A (en) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | Seal oil soft capsule |
-
2014
- 2014-06-29 CN CN201410297614.0A patent/CN104082741A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518989A (en) * | 2003-01-21 | 2004-08-11 | 刘 威 | Soft capsule of fur seal and application in preparing health products for regulating blood fat |
| WO2005075613A1 (en) * | 2004-02-06 | 2005-08-18 | Adrien Beaudoin | Method for preventing the oxidation of lipids in animal and vegetable oils and compositions produced by the method thereof |
| CN101023963A (en) * | 2007-03-28 | 2007-08-29 | 汪昔奇 | Method for preparing natural astaxanthin and fishliver oil |
| US20090297492A1 (en) * | 2008-05-30 | 2009-12-03 | Yamaha Hatsudoki Kabushiki Kaisha | Method for Improving Cognitive Performance |
| CN103608022A (en) * | 2011-05-31 | 2014-02-26 | 日本水产株式会社 | Brain function improving agent |
| CN103800435A (en) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | Seal oil soft capsule |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107080769A (en) * | 2017-05-17 | 2017-08-22 | 王茹 | A kind of natural drug for treating various chronic diseases and medical formula food |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104082751A (en) | Deep sea fish oil soft capsule containing astaxanthin | |
| JP2002540221A (en) | Process of converting refined triglycerides from marine sources into mildly stable oils | |
| CN103444911A (en) | Medicinal and edible health care blending oil | |
| Asif | Chemical characteristics and nutritional potentials of unsaturated fatty acids | |
| US20110244052A1 (en) | Polyunsaturated fatty acids for improving vision | |
| WO2010149662A1 (en) | Composition comprising omega-7 and/or omega-4 fatty acids | |
| CN104055123A (en) | Gamma-linolenic acid containing deep sea fish oil soft capsule | |
| CN103989179A (en) | Deep sea fish oil soft capsule containing ginkgo leaf extract | |
| CN101961352A (en) | Self-emulsified fish oil soft capsules without fishy smell | |
| JP6083942B2 (en) | Composition comprising long life grass and seafood oil | |
| CN104000208A (en) | Soft deep sea fish oil capsule containing squalene | |
| CN103989181A (en) | Walnut oil-containing fish oil soft capsule | |
| CN105963350A (en) | A natural vitamin e soft capsule | |
| EA028641B1 (en) | Edible lipid composition comprising stearidonic acid and olive oil | |
| CN104082741A (en) | Soft seal oil capsule containing astaxanthin | |
| CN103989180B (en) | Deep-sea fish oil soft capsules containing Salvia root P.E | |
| CN101194913A (en) | Natural seal oil compression biological preparation for treating hyperlipidemia and technique of preparing the same | |
| CN103989176B (en) | Deep-sea fish oil soft capsules containing kudzu root extract | |
| CN104666370A (en) | Deep sea fish oil soft capsules and preparation method thereof | |
| CN103989175A (en) | Deep sea fish oil soft capsule containing apocynum venetum extract | |
| CN104187727A (en) | Seal oil soft capsule containing salvia miltiorrhiza extract | |
| CN104187676A (en) | Seal oil soft capsule containing kudzuvine root extract | |
| CN103989185A (en) | Deep sea fish oil soft capsule containing coenzyme Q | |
| CN104055117A (en) | Seal oil soft capsule containing arachidonic acid | |
| CN104432032A (en) | Health food capable of reducing blood fat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141008 |